155 related articles for article (PubMed ID: 2877842)
1. Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys.
Beardsley PM; Balster RL; Harris LS
Drug Alcohol Depend; 1986 Oct; 18(2):149-57. PubMed ID: 2877842
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys.
Lile JA; Ross JT; Nader MA
Drug Alcohol Depend; 2005 May; 78(2):135-40. PubMed ID: 15845316
[TBL] [Abstract][Full Text] [Related]
3. The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline.
Kamien JB; Johanson CE; Schuster CR; Woolverton WL
Drug Alcohol Depend; 1986 Oct; 18(2):139-47. PubMed ID: 2877841
[TBL] [Abstract][Full Text] [Related]
4. Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon.
Lamb RJ; Griffiths RR
Psychopharmacology (Berl); 1987; 91(3):268-72. PubMed ID: 2882537
[TBL] [Abstract][Full Text] [Related]
5. Self-administration of minaprine in rhesus monkeys.
Beardsley PM; Balster RL
Drug Alcohol Depend; 1987 Mar; 19(2):121-9. PubMed ID: 3582164
[TBL] [Abstract][Full Text] [Related]
6. 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement.
Fantegrossi WE; Ullrich T; Rice KC; Woods JH; Winger G
Psychopharmacology (Berl); 2002 Jun; 161(4):356-64. PubMed ID: 12073162
[TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons.
Evans SM; Johanson CE
Drug Alcohol Depend; 1986 Oct; 18(2):159-64. PubMed ID: 2877843
[TBL] [Abstract][Full Text] [Related]
8. Estimating the relative reinforcing strength of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine.
Wang Z; Woolverton WL
Psychopharmacology (Berl); 2007 Jan; 189(4):483-8. PubMed ID: 17063335
[TBL] [Abstract][Full Text] [Related]
9. Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine.
Zacny JP; Virus RM; Woolverton WL
Pharmacol Biochem Behav; 1990 Mar; 35(3):637-42. PubMed ID: 1971112
[TBL] [Abstract][Full Text] [Related]
10. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
Insel TR; Battaglia G; Johannessen JN; Marra S; De Souza EB
J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824
[TBL] [Abstract][Full Text] [Related]
11. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
Callahan PM; Appel JB
J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.
Fantegrossi WE; Woolverton WL; Kilbourn M; Sherman P; Yuan J; Hatzidimitriou G; Ricaurte GA; Woods JH; Winger G
Neuropsychopharmacology; 2004 Jul; 29(7):1270-81. PubMed ID: 15039771
[TBL] [Abstract][Full Text] [Related]
13. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys.
Kleven MS; Woolverton WL; Seiden LS
Brain Res; 1989 May; 488(1-2):121-5. PubMed ID: 2472850
[TBL] [Abstract][Full Text] [Related]
14. Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques.
Crean RD; Davis SA; Von Huben SN; Lay CC; Katner SN; Taffe MA
Neuroscience; 2006 Oct; 142(2):515-25. PubMed ID: 16876329
[TBL] [Abstract][Full Text] [Related]
15. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
Berger UV; Gu XF; Azmitia EC
Eur J Pharmacol; 1992 May; 215(2-3):153-60. PubMed ID: 1356787
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
Slikker W; Ali SF; Scallet AC; Frith CH; Newport GD; Bailey JR
Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631
[TBL] [Abstract][Full Text] [Related]
17. Ecstacy: a review of MDMA and MDA.
Climko RP; Roehrich H; Sweeney DR; Al-Razi J
Int J Psychiatry Med; 1986-1987; 16(4):359-72. PubMed ID: 2881902
[TBL] [Abstract][Full Text] [Related]
18. The effect of MDMA ("Ecstasy") and its optical isomers on schedule-controlled responding in mice.
Glennon RA; Little PJ; Rosecrans JA; Yousif M
Pharmacol Biochem Behav; 1987 Feb; 26(2):425-6. PubMed ID: 2883666
[TBL] [Abstract][Full Text] [Related]
19. MDMA (3,4-methylenedioxymethamphetamine): proceedings of the conference. May 17-18, 1986, Oakland, California.
J Psychoactive Drugs; 1986; 18(4):287-379. PubMed ID: 2880942
[No Abstract] [Full Text] [Related]
20. MDMA as a discriminative stimulus: isomeric comparisons.
Schechter MD
Pharmacol Biochem Behav; 1987 May; 27(1):41-4. PubMed ID: 2886996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
